Pharmacological validation of dihydrofolate reductase as a drug target in Mycobacterium abscessus .

MLA

Aragaw, Wassihun Wedajo, et al. “Pharmacological Validation of Dihydrofolate Reductase as a Drug Target in Mycobacterium Abscessus .” Antimicrobial Agents and Chemotherapy, vol. 68, no. 1, Jan. 2024, p. e0071723. EBSCOhost, https://doi.org/10.1128/aac.00717-23.

APA

Aragaw, W. W., Negatu, D. A., Bungard, C. J., Dartois, V. A., Marrouni, A. E., Nickbarg, E. B., Olsen, D. B., Warrass, R., & Dick, T. (2024). Pharmacological validation of dihydrofolate reductase as a drug target in Mycobacterium abscessus . Antimicrobial Agents and Chemotherapy, 68(1), e0071723. https://doi.org/10.1128/aac.00717-23

Chicago

Aragaw, Wassihun Wedajo, Dereje A Negatu, Christopher J Bungard, Véronique A Dartois, Abdellatif El Marrouni, Elliott B Nickbarg, David B Olsen, Ralf Warrass, and Thomas Dick. 2024. “Pharmacological Validation of Dihydrofolate Reductase as a Drug Target in Mycobacterium Abscessus .” Antimicrobial Agents and Chemotherapy 68 (1): e0071723. doi:10.1128/aac.00717-23.